Interestingly, patients with germline MEN1 mutations and lung NETs have a favorable prognosis, possibly owing to early screening that identifies 86% of tumors, allowing timely curative treatment (72, 73). This evidence concerns the gene MEN1 and lung neuroendocrine neoplasm.